According to IMARC Group, the global Vascular Grafts Market Size reached USD 2.1 Billion in 2025 and is projected to reach USD 3.4 Billion by 2034, expanding at a CAGR of 5.20% during 2026–2034. This consistent Vascular Grafts Market Growth reflects the rising number of fatal road accidents and trauma cases, growing inclination towards medical tourism, and an increasing number of surgical procedures, particularly among the geriatric population.

Vascular Grafts Industry Overview

Vascular grafts are medical devices used to replace, bypass, or restore functionality to damaged or diseased blood vessels in the human body. Serving as artificial conduits, they facilitate blood flow and ensure that vital organs and tissues receive an adequate blood supply. Grafts can be constructed from synthetic polymers such as Dacron and Teflon, or from biological materials like vein segments harvested from the patient or a donor.

These devices are deployed across a broad continuum of surgical use cases:

• Coronary artery bypass grafting (CABG): Rerouting blood flow around blocked or compromised coronary arteries
• Hemodialysis access: Creating durable arteriovenous (AV) access points for patients undergoing long-term dialysis
• Aortic aneurysm repair: Endovascular and open surgical repair of abdominal and thoracic aortic aneurysms
• Peripheral artery bypass: Restoring circulation in patients with peripheral vascular occlusion
• Trauma and reconstructive surgery: Emergency vascular repair following road accidents and traumatic injury

Request for a Sample Report for Detailed Vascular Grafts Market Share Evaluation: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Global Vascular Grafts Market Size & Key Statistics

Below are the key Vascular Grafts Market statistics drawn from IMARC Group's comprehensive market analysis:

Base Year - 2025

Historical Period - 2020–2025

Forecast Period - 2026–2034

Vascular Grafts Market Size in 2025 - USD 2.1 Billion

Market Forecast in 2034 - USD 3.4 Billion

Market Growth Rate (2026–2034) - 5.20% CAGR

Largest Region - North America

Leading Product Segment - Endovascular Stent Grafts

Leading Raw Material Segment - Polytetrafluoroethylene (PTFE)

Leading Application - Cardiac Aneurysm

Leading End-Use Segment - Hospitals

Key Market Drivers & Vascular Grafts Market Trends in 2026

Several powerful forces are shaping Vascular Grafts Market Trends and fuelling sustained growth expectations across global vascular surgery and cardiovascular care markets:

1. Increase in Prevalence of Lifestyle Diseases

One of the primary factors driving the demand for vascular grafts is the surging prevalence of lifestyle-related diseases like obesity and diabetes. These conditions significantly elevate the risk of developing vascular problems that may necessitate graft surgeries. As lifestyle diseases continue to surge, the requirement for vascular grafts to manage associated vascular complications is likely to grow substantially, further reinforcing Vascular Grafts Market Growth.

2. Rise in Public Awareness and Education

Increasing public awareness about vascular diseases and the available treatment options is also catalyzing demand for vascular grafts. Public health campaigns, educational programs, and digital platforms are educating people about the risks of vascular conditions and the importance of early diagnosis and treatment. This heightened awareness is leading to more people seeking medical advice and, consequently, increasing the number of vascular graft surgeries being performed.

3. Growing Regulatory Approvals and Reimbursement Policies

Favorable regulatory approvals and reimbursement policies play a crucial role in driving the market for vascular grafts. Regulatory bodies across numerous countries have stringent but clear pathways for approving new medical devices, including vascular grafts. Once approved, these products are more readily adopted by medical facilities. Comprehensive reimbursement policies further make it financially feasible for patients to opt for these advanced treatments, elevating overall Vascular Grafts Market Share for approved device categories.

4. Rising Focus on Preventive Healthcare and Ambulatory Care

An increasing focus on preventive healthcare, which leads to early diagnosis and treatment of vascular conditions, is catalyzing the need for vascular grafts as a preemptive measure. Additionally, the growing number of ambulatory surgical centers, which offer quicker and more convenient surgical procedures, is creating a positive outlook for the market and expanding the settings in which graft procedures can be performed.

5. Advances in Bioengineered and Minimally Invasive Graft Technology

Leading companies are developing bioengineered and drug-eluting grafts that incorporate living cells or biological molecules to improve biocompatibility and encourage tissue integration. Many are coated with pharmaceutical agents that slowly release into the bloodstream, reducing the risk of clot formation and vessel narrowing post-surgery. The adoption of 3D printing and nanotechnology to create custom, patient-specific grafts with better flexibility and reduced thrombogenicity is further shaping the innovation pipeline.

Key Market Segmentation

By Product

Endovascular Stent Grafts – Largest Segment: Endovascular stent grafts represent the largest product segment, used primarily for treating conditions like abdominal aortic aneurysms and thoracic aortic aneurysms. Placed using minimally invasive (MI) surgical techniques, a catheter delivers the stent graft to the affected area through a small incision, usually in the groin, generally leading to shorter recovery times and less postoperative pain.

Hemodialysis Access Grafts: These grafts provide reliable and durable vascular access for patients requiring long-term hemodialysis. Typically made of synthetic materials like PTFE, they are surgically implanted to connect an artery to a vein, usually in the arm, and offer the advantage of immediate use compared to AV fistulas, which often require weeks to mature.

Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, and Peripheral Vascular Grafts: These segments round out the product landscape, supporting bypass procedures, aortic disease management, and peripheral revascularization across diverse patient populations.

By Raw Material

Polytetrafluoroethylene (PTFE) – Largest Share: PTFE is a synthetic fluoropolymer known for its chemical inertness, biocompatibility, and low friction coefficient, making it well suited for medical applications. It is particularly popular for hemodialysis access grafts, which are often ready for immediate use after implantation.

Polyester: Widely used in aortic and peripheral vascular bypass surgeries and often sold under the brand name Dacron, polyester grafts have a well-established safety and efficacy profile spanning several decades, offering excellent tensile strength, durability, and biocompatibility that supports tissue ingrowth.

Polyurethane and Biosynthetic: These raw material categories continue to see targeted use across specialty graft applications, complementing the broader PTFE and polyester segments.

By Application

Cardiac Aneurysm – Largest Segment: Vascular grafts play a critical role in treating cardiac aneurysms, localized abnormal bulges in the wall of heart chambers or arteries. In procedures such as coronary artery bypass grafting (CABG), graft materials like polyester or PTFE are used to reroute blood flow around blocked or compromised arteries, restoring adequate blood supply to heart muscles.

Kidney Failure: Vascular grafts are commonly used to create a functional access point for hemodialysis. Hemodialysis access grafts, often made from PTFE, surgically connect an artery to a vein, usually in the arm, providing a high-flow circuit for efficient blood removal and return during dialysis sessions.

Vascular Occlusion and Coronary Artery Disease: These applications continue to drive steady graft demand across bypass and revascularization procedures worldwide.

By End User

Hospitals – Largest End-Use Segment: Hospitals account for the dominant end-use share of the Vascular Grafts Market, supported by comprehensive medical infrastructure including specialized surgical units, advanced diagnostic equipment, and postoperative care facilities that enable successful graft implantation and maintenance.

Ambulatory Surgical Centers (ASCs): ASCs serve as significant end users, with advancements in minimally invasive surgical (MIS) techniques enabling certain graft procedures, such as some endovascular stent placements, to be conducted outside of hospital settings, offering quicker patient turnover and lower cost.

Regional Vascular Grafts Market Analysis

North America – Largest

United States & Canada; surging prevalence of diabetes, rising adoption of AI and advanced diagnostic imaging, growing preference for minimally invasive surgeries

Asia-Pacific

China, Japan, India, South Korea, Australia, Indonesia; expanding healthcare infrastructure and rising surgical procedure volumes

Europe

Germany, France, UK, Italy, Spain, Russia; established graft adoption and mature vascular surgery infrastructure

Latin America

Brazil, Mexico; growing hospital infrastructure and rising surgical intervention rates

Middle East & Africa

Healthcare modernization programs supporting expanding access to vascular surgical care

North America leads the global Vascular Grafts Market Share, underpinned by the surging prevalence of diabetes, rising adoption of cutting-edge diagnostic technologies like AI and advanced imaging, and the growing preference for minimally invasive surgical procedures across the region.

Connect for Detailed Vascular Grafts Market Share Segmentation Analysis – Speak to an Analyst: https://www.imarcgroup.com/request?type=report&id=6256&flag=C

Leading Players in the Global Vascular Grafts Industry

The global vascular grafts market features a mix of diversified medical device multinationals and specialized vascular technology companies. Key players covered in the IMARC Group report include:

• Abbott Laboratories
• B. Braun SE (B. Braun Holding GmbH & Co. KG)
• Becton, Dickinson and Company
• Cook Group Incorporated
• Cordis
• CryoLife Inc.
• Getinge AB
• Heat Medical Europe BV
• LeMaitre Vascular
• Medtronic plc
• Terumo Corporation
• W. L. Gore & Associates Inc.

Leading companies are developing bioengineered and drug-eluting grafts that incorporate living cells or biological molecules to improve biocompatibility and encourage tissue integration. Key players are also adopting 3D printing technologies to create custom vascular grafts matched to individual patient anatomy, alongside nanotechnology to achieve better flexibility and reduced thrombogenicity.

About Us

IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Healthcare, Technology, Chemicals, Energy, Food & Beverages, and more.

Contact Us

IMARC Group

United States: +1-201-971-6302

India: +91-120-433-0800

United Kingdom: +44-753-714-6104